Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-01

FDA Approved: FINACEA FOAM — Supplemental Application (LEO Pharma Inc.)

View source ↗

Summary

FDA approved a supplemental application to add FINACEA FOAM, a topical azelaic acid product from LEO Pharma, for the treatment of Rosacea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FINACEA FOAM (AZELAIC ACID)

Snippet

SUPPL AP for FINACEA FOAM (AZELAIC ACID)